2014 - Fellow of the Royal Society, United Kingdom
Member of the Association of American Physicians
Fellow of The Academy of Medical Sciences, United Kingdom
His main research concerns Internal medicine, Endocrinology, Genetics, Gene and MEN1. The Internal medicine study combines topics in areas such as MEDLINE and Pathology. His study in Hypercalciuria, Hypoparathyroidism, Dent's disease, Dent Disease and Kidney is carried out as part of his studies in Endocrinology.
Rajesh V. Thakker focuses mostly in the field of Gene, narrowing it down to topics relating to Molecular biology and, in certain cases, Position effect, Days post coitum, In situ hybridization and Open reading frame. His MEN1 study incorporates themes from Pituitary neoplasm and Pituitary adenoma. His work in Multiple endocrine neoplasia addresses subjects such as Cancer research, which are connected to disciplines such as Loss of heterozygosity, Germline, Chromosome 18 and Foregut.
Rajesh V. Thakker focuses on Internal medicine, Endocrinology, Genetics, Gene and Multiple endocrine neoplasia. His Internal medicine study which covers Missense mutation that intersects with Frameshift mutation. In Endocrinology, Rajesh V. Thakker works on issues like Calcium-sensing receptor, which are connected to Cell biology.
He works mostly in the field of Genetics, limiting it down to topics relating to Molecular biology and, in certain cases, Mutant, as a part of the same area of interest. In his research on the topic of Multiple endocrine neoplasia, Loss of heterozygosity is strongly related with Pathology. His work deals with themes such as Germline mutation and Oncology, which intersect with MEN1.
Rajesh V. Thakker mostly deals with Internal medicine, Endocrinology, Calcium-sensing receptor, Multiple endocrine neoplasia and MEN1. Internal medicine and Mutation are frequently intertwined in his study. He interconnects Calcium metabolism, Parathyroid hormone, Calcium, Mutant and Receptor in the investigation of issues within Endocrinology.
His Calcium-sensing receptor research includes themes of Signal transduction, G protein-coupled receptor, MAPK/ERK pathway and Cell biology. Rajesh V. Thakker has researched Multiple endocrine neoplasia in several fields, including Neuroendocrine tumors and Somatostatin. His work is dedicated to discovering how MEN1, Cancer research are connected with Epigenetics, Germline, PI3K/AKT/mTOR pathway, Carcinogenesis and Germline mutation and other disciplines.
Rajesh V. Thakker mainly focuses on Internal medicine, Endocrinology, Calcium-sensing receptor, Mutation and Genetics. Many of his studies involve connections with topics such as Multiple endocrine neoplasia and Internal medicine. His Multiple endocrine neoplasia study combines topics in areas such as Neuroendocrine tumors and Somatostatin.
His studies in Endocrinology integrate themes in fields like Receptor, Calcium in biology and MEDLINE. His Calcium-sensing receptor research integrates issues from Cancer research and Signal transduction, G protein-coupled receptor. His Mutation research incorporates themes from Somatic cell, Mutant, Germline and Familial hypocalciuric hypercalcemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Primer on the metabolic bone diseases and disorders of mineral metabolism
John P. Bilezikian;Roger Bouillon;Thomas Clemens;Juliet Compston.
Rhode Island dental journal (2013)
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Maria Luisa Brandi;Robert F. Gagel;Alberto Angeli;John P. Bilezikian.
The Journal of Clinical Endocrinology and Metabolism (2001)
Gastroenteropancreatic neuroendocrine tumours.
Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen.
Lancet Oncology (2008)
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)
Rajesh V. Thakker;Paul J. Newey;Gerard V. Walls;John Bilezikian.
The Journal of Clinical Endocrinology and Metabolism (2012)
Guidelines for the management of thyroid cancer
Petros Perros;Kristien Boelaert;Steve Colley;Carol Evans.
Clinical Endocrinology (2014)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John K Ramage;A Ahmed;J Ardill;N Bax.
Identification of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene. The European Consortium on MEN1
Irma Lemmens;Wim J. M. Van de Ven;Koen Kas;Chang X. Zhang.
Human Molecular Genetics (1997)
A common molecular basis for three inherited kidney stone diseases
Sarah E. Lloyd;Simon H. S. Pearce;Simon E. Fisher;Klaus Steinmeyer.
HRPT2 , encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome
J.D. Carpten;C.M. Robbins;A. Villablanca;L. Forsberg.
Nature Genetics (2002)
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
Manuel C. Lemos;Rajesh V. Thakker.
Human Mutation (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: